A Reversible Gene-Targeting Strategy Identifies Synthetic Lethal Interactions between MK2 and p53 in the DNA Damage Response In Vivo
A fundamental limitation in devising new therapeutic strategies for killing cancer cells with DNA damaging agents is the need to identify synthetic lethal interactions between tumor-specific mutations and components of the DNA damage response (DDR) in vivo. The stress-activated p38 mitogen-activated...
Main Authors: | Reinhardt, H. Christian, Kim, Jacob S., Ruf, Daniela M., Mitra, Tanya, Couvillon, Anthony D., Yaffe, Michael B., Cannell, Ian Gordon, Reinhardt, H. Christian, Kim, Jacob S., Ruf, Daniela M., Morandell, Sandra M., Jacks, Tyler E, Yaffe, Michael B |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biological Engineering |
Format: | Article |
Language: | en_US |
Published: |
Elsevier
2014
|
Online Access: | http://hdl.handle.net/1721.1/90556 https://orcid.org/0000-0001-5785-8911 https://orcid.org/0000-0002-9547-3251 |
Similar Items
-
Exploiting synthetic lethal interactions for targeted cancer therapy
by: Reinhardt, H. Christian, et al.
Published: (2012) -
DNA Damage Activates a Spatially Distinct Late Cytoplasmic Cell-Cycle Checkpoint Network Controlled by MK2-Mediated RNA Stabilization
by: Reinhardt, H. Christian, et al.
Published: (2014) -
MK2 contributes to tumor progression by promoting M2 macrophage polarization and tumor angiogenesis
by: Haigis, Kevin M., et al.
Published: (2018) -
A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy
by: Grant, Robert A., et al.
Published: (2016) -
Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints
by: Kong, Yi Wen, et al.
Published: (2021)